Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-discharge malaria continuum of care trial
PACTR202605645807374Phase 4Recruiting
- Sponsor
- Training and Research Unit of Excellence
- Start
- Mar 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in malaria (2 arms), sponsored by Training and Research Unit of Excellence. Primary endpoint: Complete PDMCC drug uptake. Started Mar 2025; status: recruiting.
02
Conditions
malaria
Beyond the preview
Go deeper on PACTR202605645807374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605645807374.